Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA greenlights first non-opioid treatment for severe pain in 20 years
Journavax was shown in clinical trials to be safe and effective, with no addictive potential.
PCI before TAVR linked to better outcomes than performing both at once
Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.
Swedish total artificial heart tech granted FDA’s humanitarian use designation
Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.
New findings prompt experts to call for routine brain imaging of certain breast cancer patients
New research suggests more women with late-stage breast cancer may develop brain metastases than previously believed.
Medical device company raises $36M for emitter-free IVL platform
Boston-based Amplitude Vascular Systems is busy investigating the performance of its Pulse IVL platform in a wide variety of patient populations.

FDA announces new insulin recall due to potential labeling issue

The recall is focused on a single batch distributed from December 2021 to March 2022.

Links to the ACC.22 late-breaking clinical trials

Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C.

Drug-coated balloons comparable to drug-eluting stents when PCI patients have a high bleeding risk

Drug-coated balloons were associated with a lower risk of bleeding after PCI than drug-eluting stents, the study's authors reported.

VIDEO: TAVR durability outperforms surgical valves

Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.

Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.

An updated look at what cardiologists know about heart damage among COVID-19 patients

An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19.

Fitbit’s latest AFib algorithm receives FDA clearance, will be available ‘soon’

The new algorithm was designed to evaluate a user's heart rhythm while they are still or even sleeping.

How the continued rise of TAVR has impacted SAVR outcomes

Did SAVR outcomes suffer due to the rapid rise of TAVR? A team of researchers aimed to find out with a brand new analysis.

Adam Greenbaum, MD, Emory, explains the CLASP TR trial of the Pascal clip device for transcatheter repair, which was a late-breaking ACC22 study.

VIDEO: Pascal effective in transcatheter repair of tricuspid valve regurgitation

Adam Greenbaum, MD, co-director of the Structural Heart and Valve Center at Emory University Hospital Midtown in Atlanta, explains details from the late-breaking CLASP TR trial at ACC.22.

Clinical

FDA greenlights first non-opioid treatment for severe pain in 20 years

PCI before TAVR linked to better outcomes than performing both at once

Swedish total artificial heart tech granted FDA’s humanitarian use designation

New findings prompt experts to call for routine brain imaging of certain breast cancer patients

Medical device company raises $36M for emitter-free IVL platform